TY - CHAP
T1 - Computational tools for allosteric drug discovery
T2 - Site identification and focus library design
AU - Huang, Wenkang
AU - Nussinov, Ruth
AU - Zhang, Jian
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2017.
PY - 2017
Y1 - 2017
N2 - Allostery is an intrinsic phenomenon of biological macromolecules involving regulation and/or signal transduction induced by a ligand binding to an allosteric site distinct from a molecule’s active site. Allosteric drugs are currently receiving increased attention in drug discovery because drugs that target allosteric sites can provide important advantages over the corresponding orthosteric drugs including specific subtype selectivity within receptor families. Consequently, targeting allosteric sites, instead of orthosteric sites, can reduce drug-related side effects and toxicity. On the down side, allosteric drug discovery can be more challenging than traditional orthosteric drug discovery due to difficulties associated with determining the locations of allosteric sites and designing drugs based on these sites and the need for the allosteric effects to propagate through the structure, reach the ligand binding site and elicit a conformational change. In this study, we present computational tools ranging from the identification of potential allosteric sites to the design of “allosteric-like” modulator libraries. These tools may be particularly useful for allosteric drug discovery.
AB - Allostery is an intrinsic phenomenon of biological macromolecules involving regulation and/or signal transduction induced by a ligand binding to an allosteric site distinct from a molecule’s active site. Allosteric drugs are currently receiving increased attention in drug discovery because drugs that target allosteric sites can provide important advantages over the corresponding orthosteric drugs including specific subtype selectivity within receptor families. Consequently, targeting allosteric sites, instead of orthosteric sites, can reduce drug-related side effects and toxicity. On the down side, allosteric drug discovery can be more challenging than traditional orthosteric drug discovery due to difficulties associated with determining the locations of allosteric sites and designing drugs based on these sites and the need for the allosteric effects to propagate through the structure, reach the ligand binding site and elicit a conformational change. In this study, we present computational tools ranging from the identification of potential allosteric sites to the design of “allosteric-like” modulator libraries. These tools may be particularly useful for allosteric drug discovery.
KW - Allosteric drug design
KW - Allosteric drug discovery
KW - Allosteric modulator
KW - Allosteric site
KW - Allostery
UR - http://www.scopus.com/inward/record.url?scp=85006021786&partnerID=8YFLogxK
U2 - 10.1007/978-1-4939-6637-0_23
DO - 10.1007/978-1-4939-6637-0_23
M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???
C2 - 27914066
AN - SCOPUS:85006021786
T3 - Methods in Molecular Biology
SP - 439
EP - 446
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -